Drug Development

Market Trends Innovative Medicines Clinical Trials mRNA Technology Antibiotics Market Strategy Workforce Needs Cancer Drugs B Cell Therapies NASH Cirrhotics

3 ARTICLES

2w ago

Insilico and SK Biopharmaceuticals Sign $2.5 Billion AI Drug Discovery Deal for Neuroimmune Therapies

The deal links Insilico's Pharma.AI discovery engine to SK's late‑stage development and U.S. commercialization to speed candidate advancement through milestone‑based payments.

6 ARTICLES

last mo.

Sanofi, Dren Bio Set Autoimmune Collaboration Worth Up to $1.7 Billion With $100 Million Upfront

5 ARTICLES

9mo ago

German Antitrust Watchdog Clears BioNTech’s CureVac Takeover

6 ARTICLES

this yr.

Wockhardt Liquidates US Generics Units to Fuel Antibiotic and Insulin Innovation

12 ARTICLES

2y ago

New Male Birth Control Gel Shows Rapid and Promising Results

Drug Development

Insilico and SK Biopharmaceuticals Sign $2.5 Billion AI Drug Discovery Deal for Neuroimmune Therapies

Bristol Myers Squibb to Deploy Anthropic’s Claude Across Global Operations

Bristol Myers and Hengrui Ink Up to $15.2 Billion Drug Discovery Alliance

AstraZeneca Revives UK Plans With £300 Million for Cambridge and Macclesfield

Sanofi, Dren Bio Set Autoimmune Collaboration Worth Up to $1.7 Billion With $100 Million Upfront

German Antitrust Watchdog Clears BioNTech’s CureVac Takeover

Wockhardt Liquidates US Generics Units to Fuel Antibiotic and Insulin Innovation

New Male Birth Control Gel Shows Rapid and Promising Results